The virtual disappearance of injectable opioids for heroin addiction under the ‘British System’

References

• Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. The Journal of Substance Abuse Treatment 2005; 28: 321–329
   PubMed Web of Science ®Google Scholar
• Audit Commission. Changing habits: The commissioning and management of community drug treatment services for adults. Audit Commission Publications, Wetherby 2002
   Google Scholar
• Department of Health. Drug misuse and dependence: guidelines on clinical management. HMSO, London 1999
   Google Scholar
• Department of Health. Drug misuse and dependence: UK guidelines on clinical management. Department of Health, London 2007
   Google Scholar
• Department of Health. ‘Drugs: Protecting families and communities’–The 2008 drug strategy. HM Government, London 2008
   Google Scholar
• Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, et al. Heroin-assisted treatment (HAT) a decade later: A brief update on science and politics. Journal of Urban Health 2007; 84: 552–562
   PubMed Web of Science ®Google Scholar
• Fischer B, Rehm J, Kirst M, Casas M, Hall W, Krausz M, et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence. The European Journal of Public Health 2002; 12: 228–234
   PubMed Web of Science ®Google Scholar
• Gilvarry E. Commentary on: New guidelines for prescribing injectable heroin in opiate addiction. Psychiatric Bulletin 2005; 29: 128–130
   Google Scholar
• Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. The British Journal of Psychiatry 2007; 191: 55–62
   PubMed Web of Science ®Google Scholar
• Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, et al. The effect of adherence to practice guidelines on depression outcomes. Annals of Internal Medicine 2007; 147: 320–329
   PubMed Web of Science ®Google Scholar
• Lintzeris N. Prescription of heroin for the management of heroin dependence: Current status. CNS Drugs 2009; 23: 463–476
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Strang J, Metrebian N, Byford S, Hallam C, Lee S, et al. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): Evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduction Journal 2006; 3: 28
   PubMedGoogle Scholar
• Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008; 2: CD002207
   PubMed Web of Science ®Google Scholar
• Metrebian N, Carnwath Z, Mott J, Carnwath T, Stimson GV, Sell L. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug and Alcohol Review 2006; 25: 115–121
   PubMed Web of Science ®Google Scholar
• Metrebian N, Carnwath T, Stimson GV, Storz T. Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction 2002; 97: 1155–1161
   PubMed Web of Science ®Google Scholar
• Metrebian N, Mott J, Carnwath Z, Carnwath T, Stimson GV, Sell L. Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United kingdom. European Addiction Research 2007; 13: 144–147
   PubMed Web of Science ®Google Scholar
• National Treatment Agency. Potential roles in drug treatment: Executive summary. National Treatment Agency, LondonUnited Kingdom 2003
   Google Scholar
• Perneger TV, Giner F, del Rio M, Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal 1998; 317: 13–18
   PubMed Web of Science ®Google Scholar
• Sell L, Zador D. Patients prescribed injectable heroin or methadone–their opinions and experiences of treatment. Addiction 2004; 99: 442–449
   PubMed Web of Science ®Google Scholar
• Sheridan J, Manning V, Ridge G, Mayet S, Strang J. Community pharmacies and the provision of opioid substitution services for drug misusers: Changes in activity and attitudes of community pharmacists across England 1995–2005. Addiction 2007; 102: 1824–1830
   PubMed Web of Science ®Google Scholar
• Strang J, Manning V, Mayet S, Ridge G, Best D, Sheridan J. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995–2005. Addiction 2007; 102: 761–770
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J. Heroin prescribing in the “British System” of the mid-1990s: Data from the 1995 national survey of community pharmacies in England and Wales. Drug Alcohol Rev. 1997; 16: 7–16
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J. Methadone prescribing to opiate addicts by private doctors: Comparison with NHS practice in south east England. Addiction 2001; 96: 567–576
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: Results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ 1996; 313: 270–272
   PubMed Web of Science ®Google Scholar
• van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal 2003; 327: 310
   PubMed Web of Science ®Google Scholar